US EditionFirst Negotiated Medicare Drug Prices Go Into Effect Jan. 1
Medicare Part D and Advantage plans now benefit from negotiated drug prices cutting list prices by 38% to 79%, reducing costs for millions of beneficiaries.
- The Medicare Drug Price Negotiation Program required Health and Human Services to negotiate maximum prices for 10 popular drugs each year starting in 2026.
- The negotiated prices for drugs like Eliquis, Enbrel, and Januvia range from 38% to 79% below their list prices and went into effect on January 1, 2023.
- Any savings for Medicare Part D and Advantage plan enrollees depend largely on which specific plan they are enrolled in.
48 Articles
48 Articles
Savings for Part D affiliates and Advantage plans depend to a large extent on the plan in which they are registered, as not all plans are the same.
First negotiated Medicare drug prices went into effect Jan. 1
Photo: Alan Wooten / The Center Square By Morgan Sweeney, for The Center Square (The Center Square) – Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday. How much those savings will be passed on to Medicare Part D and applicable Advantage plan enrollees is unclear, however, as drug pricing and reimbursement is notoriously complex and opaque, though lawmakers have pushed for more transparency in recent ye…
Medicare's Drug Price Bombshell, 79% Cuts Hit Big Pharma
Negotiated lower costs for 10 widely used prescription drugs under Medicare went into effect Thursday, marking the first implementation of price limits authorized by the 2022 Inflation Reduction Act. The changes cap what drug manufacturers can charge Medicare plans for select medications, but it remains unclear how much of those savings will flow directly to Medicare Part D and Medicare Advantage enrollees, given the complexity and opacity of dr…
Coverage Details
Bias Distribution
- 46% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
